U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubChem Substance

Items: 1 to 20 of 147

1.
Challenges in management of complex panic disorder in a palliative care setting
Itoro Udo, Amanda Gash
BMJ Case Rep. 2012; 2012: bcr2012006800. Published online 2012 Oct 9. doi: 10.1136/bcr-2012-006800
PMCID:
PMC4544155
AbstractArticlePDF–143K
2.
Mirtazapine versus other antidepressive agents for depression
Norio Watanabe, Ichiro M Omori, Atsuo Nakagawa, Andrea Cipriani, Corrado Barbui, Rachel Churchill, Toshi A Furukawa
Cochrane Database Syst Rev. Author manuscript; available in PMC 2014 Sep 9.
Published in final edited form as: Cochrane Database Syst Rev. 2011; (12): CD006528. Published online 2011 Dec 7. doi: 10.1002/14651858.CD006528.pub2
PMCID:
PMC4158430
AbstractArticlePDF–13M
3.
Road traffic accidents: more than just whiplash?
Heather Counsell, Sophie Johnson
BMJ Case Rep. 2013; 2013: bcr2012007832. Published online 2013 Jan 22. doi: 10.1136/bcr-2012-007832
PMCID:
PMC3603599
AbstractArticlePDF–54K
4.
Bupropion, Bayesian Logic and Serotonin Toxicity
P. Ken Gillman
J Med Toxicol. 2010 Jun; 6(2): 276–277. Published online 2010 May 4. doi: 10.1007/s13181-010-0084-8
PMCID:
PMC3550296
SummaryPDF–60K
5.
EARLY ADVERSITY IN CHRONIC DEPRESSION: CLINICAL CORRELATES AND RESPONSE TO PHARMACOTHERAPY
Daniel N. Klein, Bruce A. Arnow, Jennifer L. Barkin, Frank Dowling, James H. Kocsis, Andrew C. Leon, Rachel Manber, Barbara O. Rothbaum, Madhukar H. Trivedi, Stephen R. Wisniewski
Depress Anxiety. Author manuscript; available in PMC 2012 Dec 21.
Published in final edited form as: Depress Anxiety. 2009; 26(8): 701–710. doi: 10.1002/da.20577
PMCID:
PMC3528400
AbstractArticlePDF–444K
6.
The atypical antidepressant mianserin exhibits agonist activity at κ-opioid receptors
Maria C Olianas, Simona Dedoni, Pierluigi Onali
Br J Pharmacol. 2012 Nov; 167(6): 1329–1341. doi: 10.1111/j.1476-5381.2012.02078.x
PMCID:
PMC3504997
AbstractArticlePDF–1.6M
7.
Mirtazapine, and mirtazapine-like compounds as possible pharmacotherapy for substance abuse disorders: Evidence from the bench and the bedside
Steven M. Graves, Roueen Rafeyan, Jeffrey Watts, T. Celeste Napier
Pharmacol Ther. Author manuscript; available in PMC 2013 Dec 1.
Published in final edited form as: Pharmacol Ther. 2012 Dec; 136(3): 343–353. Published online 2012 Aug 29. doi: 10.1016/j.pharmthera.2012.08.013
PMCID:
PMC3483434
AbstractArticlePDF–812K
8.
The atypical antidepressant mirtazapine attenuates expression of morphine-induced place preference and motor sensitization
Steven M. Graves, Amanda L. Persons, Jennifer L. Riddle, T. Celeste Napier
Brain Res. Author manuscript; available in PMC 2013 Sep 7.
Published in final edited form as: Brain Res. 2012 Sep 7; 1472: 45–53. Published online 2012 Jul 20. doi: 10.1016/j.brainres.2012.07.007
PMCID:
PMC3440179
AbstractArticlePDF–891K
9.
Mirtazapine to Reduce Methamphetamine Use: A Randomized Controlled Trial
Grant N. Colfax, Glenn-Milo Santos, Moupali Das, Deirdre McDermott Santos, Tim Matheson, James Gasper, Steve Shoptaw, Eric Vittinghoff
Arch Gen Psychiatry. Author manuscript; available in PMC 2012 Sep 10.
Published in final edited form as: Arch Gen Psychiatry. 2011 Nov; 68(11): 1168–1175. doi: 10.1001/archgenpsychiatry.2011.124
PMCID:
PMC3437988
AbstractArticlePDF–784K
10.
The first 100 patients in the SUN(^_^)D trial (strategic use of new generation antidepressants for depression): examination of feasibility and adherence during the pilot phase
Shinji Shimodera, Tadashi Kato, Hirotoshi Sato, Kazuhira Miki, Yoshihiro Shinagawa, Masaki Kondo, Hirokazu Fujita, Ippei Morokuma, Yoshio Ikeda, Tatsuo Akechi, Norio Watanabe, Mitsuhiko Yamada, Masatoshi Inagaki, Naohiro Yonemoto, Toshi A Furukawa
Trials. 2012; 13: 80. Published online 2012 Jun 8. doi: 10.1186/1745-6215-13-80
PMCID:
PMC3409023
AbstractArticlePDF–694K
11.
Mirtazapine Inhibits Tumor Growth via Immune Response and Serotonergic System
Chun-Kai Fang, Hong-Wen Chen, I-Tsang Chiang, Chia-Chieh Chen, Jyh-Fei Liao, Ton-Ping Su, Chieh-Yin Tung, Yosuke Uchitomi, Jeng-Jong Hwang
PLoS One. 2012; 7(7): e38886. Published online 2012 Jul 13. doi: 10.1371/journal.pone.0038886
PMCID:
PMC3396612
AbstractArticlePDF–2.2M
12.
Intervention of Mirtazapine on gemcitabine-induced mild cachexia in nude mice with pancreatic carcinoma xenografts
Shu-Man Jiang, Jian-Hua Wu, Lin Jia
World J Gastroenterol. 2012 Jun 14; 18(22): 2867–2871. Published online 2012 Jun 14. doi: 10.3748/wjg.v18.i22.2867
PMCID:
PMC3374993
AbstractArticlePDF–708K
13.
The Effect of Concurrent Substance Use Disorder on the Effectiveness of Single and Combination Antidepressant Medications for the Treatment of Major Depression: An Exploratory Analysis of a Single-Blind Randomized Trial
Lori L. Davis, Patricia Pilkinton, Stephen R. Wisniewski, Madhukar H. Trivedi, Bradley Gaynes, Robert H. Howland, Sidney Zisook, G.K. Balasubramani, Maurizio Fava, A. John Rush
Depress Anxiety. Author manuscript; available in PMC 2013 Feb 1.
Published in final edited form as: Depress Anxiety. 2012 Feb; 29(2): 111–122. doi: 10.1002/da.20918
PMCID:
PMC3325509
AbstractArticlePDF–1.0M
14.
Effects of Baclofen and Mirtazapine on a Laboratory Model of Marijuana Withdrawal and Relapse
Margaret Haney, Carl L. Hart, Suzanne K. Vosburg, Sandra D. Comer, Stephanie Collins Reed, Ziva D. Cooper, Richard W. Foltin
Psychopharmacology (Berl) Author manuscript; available in PMC 2012 Apr 10.
Published in final edited form as: Psychopharmacology (Berl). 2010 Aug; 211(2): 233–244. Published online 2010 Jun 3. doi: 10.1007/s00213-010-1888-6
PMCID:
PMC3323354
AbstractArticlePDF–284K
15.
Prolonged QTc Interval and Torsades de Pointes Induced by Citalopram
Anand Deshmukh, Kyle Ulveling, Venkata Alla, Hussam Abuissa, Kelly Airey
Tex Heart Inst J. 2012; 39(1): 68–70.
PMCID:
PMC3298934
AbstractArticlePDF–33M
16.
Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: Results from the CO-MED Trial
Edward S. Friedman, Lori L. Davis, Sidney Zisook, Stephen R. Wisniewski, Madhukar H. Trivedi, Maurizio Fava, A. John Rush, COMED Study Team
Eur Neuropsychopharmacol. Author manuscript; available in PMC 2013 Mar 1.
Published in final edited form as: Eur Neuropsychopharmacol. 2012 Mar; 22(3): 183–199. Published online 2011 Sep 14. doi: 10.1016/j.euroneuro.2011.07.010
PMCID:
PMC3273676
AbstractArticlePDF–371K
17.
Inhibition of G Protein-Activated Inwardly Rectifying K+ Channels by Different Classes of Antidepressants
Toru Kobayashi, Kazuo Washiyama, Kazutaka Ikeda
PLoS One. 2011; 6(12): e28208. Published online 2011 Dec 2. doi: 10.1371/journal.pone.0028208
PMCID:
PMC3229538
AbstractArticlePDF–421K
18.
Progressive Multifocal Leukoencephalopathy Associated with Isolated CD8+ T-Lymphocyte Deficiency Mimicking Tumefactive MS
Jennifer L McGuire, Vera Fridman, Christian Wüthrich, Igor J. Koralnik, Dina Jacobs
J Neurovirol. Author manuscript; available in PMC 2012 Oct 1.
Published in final edited form as: J Neurovirol. 2011 Oct; 17(5): 500–503. Published online 2011 Jul 23. doi: 10.1007/s13365-011-0045-2
PMCID:
PMC3204182
AbstractArticlePDF–325K
19.
Measuring Caenorhabditis elegans Life Span in 96 Well Microtiter Plates
Gregory M. Solis, Michael Petrascheck
J Vis Exp. 2011; (49): 2496. Published online 2011 Mar 18. doi: 10.3791/2496
PMCID:
PMC3197298
AbstractArticlePDF–224K
20.
Dopamine and Octopamine Influence Avoidance Learning of Honey Bees in a Place Preference Assay
Maitreyi Agarwal, Manuel Giannoni Guzmán, Carla Morales-Matos, Rafael Alejandro Del Valle Díaz, Charles I. Abramson, Tugrul Giray
PLoS One. 2011; 6(9): e25371. Published online 2011 Sep 30. doi: 10.1371/journal.pone.0025371
PMCID:
PMC3184138
AbstractArticlePDF–306K

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

You are here: NCBI > Literature > PubMed Central (PMC)
Support Center